FDA issued a Warning Letter to Frontida BioPharm Inc on 8/15/2016 for a later inspection.
483 Frontida BioPharm Sep 2005

483 Frontida BioPharm Sep 2005

Lisa Bellows FDA, Kristina Donohue FDA$595.00 - Available Now

FDA investigators audited the Frontida BioPharm - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 12 Sep 2005.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Sep 2005
  • Location: Philadelphia, United States
  • FEI: 2523348
Add To Cart